Cargando…

Cachexia vs obesity: where is the real unmet clinical need?

A striking discrepancy exists in the number of publications on obesity as compared to cachexia or wasting disorders. In PubMed, the number of entries that contain “cachexia” as a title word is only 1,825, whereas the number of entries for “obesity” in the title is 47,828, giving a ratio of 1:26 in f...

Descripción completa

Detalles Bibliográficos
Autores principales: von Haehling, Stephan, Anker, Stefan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830007/
https://www.ncbi.nlm.nih.gov/pubmed/24197816
http://dx.doi.org/10.1007/s13539-013-0124-8
_version_ 1782291430959480832
author von Haehling, Stephan
Anker, Stefan D.
author_facet von Haehling, Stephan
Anker, Stefan D.
author_sort von Haehling, Stephan
collection PubMed
description A striking discrepancy exists in the number of publications on obesity as compared to cachexia or wasting disorders. In PubMed, the number of entries that contain “cachexia” as a title word is only 1,825, whereas the number of entries for “obesity” in the title is 47,828, giving a ratio of 1:26 in favor of “obesity” publications. The difference in publication activities in these two fields has further broadened over the last years. Looking at guidance from national or international guidelines, PubMed analysis is even more depressing with 147 entries for obesity, but only four for cachexia. None of the latter provides guidance for the everyday care of cachectic patients. This publication activity is in stark contrast to the mortality impact of cachexia vs obesity at the time of diagnosis, which is at least 20 times higher for cachexia over the first 5 years. We assume, the mismatch is even bigger when it comes to public research support for these two medical conditions, which likely is a big part of the reason for this publication imbalance. Another reason may be that there is a perception bias in the research community, the public and hence also among healthcare providers and politicians as to what is important in medicine. We think, cachexia is at least as big an unmet need as is obesity. For shorter-term outcomes, cachexia is certainly a much bigger medical need than obesity. We hope that the current research efforts will change the situation for the better of our patients.
format Online
Article
Text
id pubmed-3830007
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-38300072013-12-01 Cachexia vs obesity: where is the real unmet clinical need? von Haehling, Stephan Anker, Stefan D. J Cachexia Sarcopenia Muscle Editorial A striking discrepancy exists in the number of publications on obesity as compared to cachexia or wasting disorders. In PubMed, the number of entries that contain “cachexia” as a title word is only 1,825, whereas the number of entries for “obesity” in the title is 47,828, giving a ratio of 1:26 in favor of “obesity” publications. The difference in publication activities in these two fields has further broadened over the last years. Looking at guidance from national or international guidelines, PubMed analysis is even more depressing with 147 entries for obesity, but only four for cachexia. None of the latter provides guidance for the everyday care of cachectic patients. This publication activity is in stark contrast to the mortality impact of cachexia vs obesity at the time of diagnosis, which is at least 20 times higher for cachexia over the first 5 years. We assume, the mismatch is even bigger when it comes to public research support for these two medical conditions, which likely is a big part of the reason for this publication imbalance. Another reason may be that there is a perception bias in the research community, the public and hence also among healthcare providers and politicians as to what is important in medicine. We think, cachexia is at least as big an unmet need as is obesity. For shorter-term outcomes, cachexia is certainly a much bigger medical need than obesity. We hope that the current research efforts will change the situation for the better of our patients. Springer Berlin Heidelberg 2013-11-07 2013-12 /pmc/articles/PMC3830007/ /pubmed/24197816 http://dx.doi.org/10.1007/s13539-013-0124-8 Text en © Springer-Verlag Berlin Heidelberg 2013
spellingShingle Editorial
von Haehling, Stephan
Anker, Stefan D.
Cachexia vs obesity: where is the real unmet clinical need?
title Cachexia vs obesity: where is the real unmet clinical need?
title_full Cachexia vs obesity: where is the real unmet clinical need?
title_fullStr Cachexia vs obesity: where is the real unmet clinical need?
title_full_unstemmed Cachexia vs obesity: where is the real unmet clinical need?
title_short Cachexia vs obesity: where is the real unmet clinical need?
title_sort cachexia vs obesity: where is the real unmet clinical need?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830007/
https://www.ncbi.nlm.nih.gov/pubmed/24197816
http://dx.doi.org/10.1007/s13539-013-0124-8
work_keys_str_mv AT vonhaehlingstephan cachexiavsobesitywhereistherealunmetclinicalneed
AT ankerstefand cachexiavsobesitywhereistherealunmetclinicalneed